Search company, investor...


Angel | Alive

About SpheriTech

SpheriTech is a company that specializes in the production of polymer microparticles and related products in the life sciences industry. The company offers a range of products including fluorescent microspheres, coated particles, and magnetic nanoparticles, which are used in various applications such as flow cytometry, cell counting, and calibration. SpheriTech primarily serves the life sciences sector. It is based in Libertyville, Illinois.

Headquarters Location

1840 Industrial Drive

Libertyville, Illinois, 60048,

United States



SpheriTech's Product Videos

SpheriTech's Products & Differentiators


    Rainbow Calibration Particles, 8 peaks, 1E7/mL, 3.0-3.4 um, 5 mL


Expert Collections containing SpheriTech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SpheriTech is included in 1 Expert Collection, including Advanced Materials.


Advanced Materials

1,364 items

Companies in the advanced materials space, including polymers, biomaterials, semiconductor materials, and more

SpheriTech Patents

SpheriTech has filed 8 patents.

The 3 most popular patent topics include:

  • proteinogenic amino acids
  • blood
  • cosmetics
patents chart

Application Date

Grant Date


Related Topics




Transfusion medicine, Hematology, Paragliders, Blood, Proteinogenic amino acids


Application Date


Grant Date



Related Topics

Transfusion medicine, Hematology, Paragliders, Blood, Proteinogenic amino acids



Latest SpheriTech News

Regenerative Medicine in Action

Aug 19, 2018

13:09 EDT 19 Aug 2018 | BioNow Science firm at The Heath Business and Technical Park awarded grant to fund cutting-edge research that will revolutionize hip - joint operationsSpheriTech, a leading life science company based at The Heath Business and Technical Park in Runcorn, has been awarded a £174k grant towards pioneering work to develop technology that will revolutionise the way physicians repair joints, with a particular focus on repair of hip lesions.SpheriTech are responsible for the laboratory-based polymer development for the new treatment; JRI Orthopaedics are developing surgical instruments to deliver the technique while Cambridge University will undertake the clinical trials. The total project cost across the three partners is £781k of which £545k will be funded by the UK’s innovation agency, Innovate UK. Each year around 180,000 patients have total hip or knee replacements in the UK. Don Wellings, founder and CEO of SpheriTech, says polymers that he and his team are developing have the potential to revolutionize regenerative medicine, including treatment for joint degeneration. The company are already making great strides on spinal cord repair and skin healing.“We believe the new techniques we are developing could ultimately delay hip and other joint replacement operations and potentially make them obsolete in the coming years,” says Dr Wellings.He adds: “Treatment to hips is required when the cartilage in the joint disintegrates, eventually causing bone to rub on bone, making it painful to walk. We are developing a polymer that surgeons can insert into the hip joint which will regenerate the cartilage and the underlying bone. It means that if the joint deterioration can be caught early enough, using key-hole surgery techniques, surgeons will be able to take away the damaged tissue and replace it with SpheriTech’s polymer. “The amount of cartilage that generally needs replacing measures about 1-2cm in diameter. SpheriTech polymer, Proliferate® will be inserted into the joint through a tube, with surgeons using cameras to guide the delivery of the polymer to the prepared site. It will then regenerate the cartilage and underlying bone thus repairing the joint and avoiding the need for an intrusive and major hip-replacement operation.”Dr Wellings says the Innovate UK funding will help fund two years of further research to develop and fine-tune the polymer and delivery technique which will be followed up by clinical studies. He believes the polymer technology will trigger repair of the hip joint within weeks.“This will revolutionize hip treatments – reducing costs to the health care industry, making treatment speedier and safer for patients, reducing post-operative care and the expense of physiotherapy. Potentially this new form of treatment could, in the longer term, minimize the need for total hip replacements altogether.” Dr Wellings adds: “The current trials are focused on hip joints but this technique can be adapted to treat knee, shoulder and elbow joints. Our polymers can also regenerate bone and we are researching how they can be introduced for the treatment of trauma injury which would also revolutionize the way surgeons treat major bone injury.”SpheriTech is also working on a project to develop synthetic blood by effectively producing artificial red blood cells. This new ‘blood substitute’, SpheriSome® Hb, could ultimately end the necessity for the blood donors’ programme. Related Biotechnology, Pharmaceutical and Healthcare News

SpheriTech Frequently Asked Questions (FAQ)

  • Where is SpheriTech's headquarters?

    SpheriTech's headquarters is located at 1840 Industrial Drive, Libertyville.

  • What is SpheriTech's latest funding round?

    SpheriTech's latest funding round is Angel.

  • Who are SpheriTech's competitors?

    Competitors of SpheriTech include Caliper Life Sciences and 6 more.

  • What products does SpheriTech offer?

    SpheriTech's products include RCP-30-5A and 4 more.


Compare SpheriTech to Competitors

Sage Science Logo
Sage Science

Sage Science specializes in automated solutions for molecular biology workflows, focusing on life science and diagnostic labs within the biotechnology sector. The company offers products for DNA size selection, high molecular weight DNA extraction, and barcode linked-read library preparation, which are designed to improve the efficiency and quality of next-generation sequencing (NGS) library construction. Sage Science's technology is utilized in applications such as DNA sequencing, RNA sequencing, genotyping, and proteomics. It is based in Beverly, Massachusetts.


Kryosphere is a full-service biorepository company operating in the biotechnology industry. The company's main services include managing, storing, and transporting biological and pharmaceutical materials, as well as providing cold chain logistics, clinical trial management, and stability storage services. Kryosphere primarily serves sectors such as academia, biopharmaceuticals, bioagriculture, and clinical research. It was founded in 2007 and is based in Durham, North Carolina.


InvivoSciences is a precision medicine company operating in the drug development and life sciences research sectors. The company's main offerings include the development of patient-derived and gene-edited human samples, specifically functional 3D engineered micro-human heart tissue platforms, which are used to personalize the drug development process. These platforms, combined with the company's integration of cell and tissue handling automation, tissue phenotyping assays, and computational biology, enable the rapid identification of safety and efficacy profiles of treatments for specific patient groups. It was founded in 2001 and is based in Wauwatosa, Wisconsin.

Informed Medical Communications

Informed Medical Communications specializes in providing communication and documentation solutions within the healthcare sector. Their main offerings include software tools that facilitate clear and efficient documentation and communication between healthcare facilities, patients, and their responsible parties. These tools are designed to educate and inform about patient conditions and assist in managing healthcare provider relationships. It is based in New York, New York.

Kiyatec Logo

Kiyatec is a functional precision oncology company operating in the healthcare and biotechnology sectors. The company's main service involves measuring the response of individual patient's live cancer cells using an innovative 3D cell culture technology platform. This technology is primarily used by biopharmaceutical companies to understand response dynamics for investigational drug candidates for use in solid tumors. It was founded in 2005 and is based in Greenville, South Carolina.

Blaze Systems Logo
Blaze Systems

Blaze Systems specializes in laboratory information management systems (LIMS) within the software industry. The company offers a comprehensive suite of LIMS solutions designed to automate laboratory operations, manage resources, and ensure regulatory compliance. Blaze Systems primarily serves sectors such as biotechnology, clinical labs, manufacturing, and pharmaceuticals. It was founded in 1991 and is based in Newark, Delaware.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.